Alamar Biosciences, Inc. cotiza a 24.24 USD y tiene una capitalización bursátil de $1.7B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) S…
| Periodo | 2026-11 | 2026-08 |
|---|---|---|
| Real | — | $-0.20 |
| Estimado | $-0.20 | $-0.32 |
| Sorpresa | — | +37.5% |
| Métrica | ALMR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | — | -32.0% | — |
| Current Ratio | 3.99 | 2.84 | +1.15 |
| Debt / Equity | — | 0.28 | — |